News

Court Reverses Health Canada’s Ban on Psilocybin Training for Clinicians

LOS ANGELES- A recent decision by the Federal Court of Appeal ruled that Health Canada’s 2022 refusal to grant exemptions allowing health-care professionals to participate in experiential psilocybin training was unreasonable. The court determined that the agency reversed its stance without offering a valid rationale, ordering the matter to be reconsidered by Minister Marjorie Mitchell. ...

June 25th, 2025|Psychedelics|

Minnesota Enacts Law Enhancing Employment Protections for Medical Cannabis Patients

LOS ANGELES— A new Minnesota law, Senate File 2370 (SF 2370), which took effect on May 24, 2025, introduces expanded employment protections for registered medical cannabis patients. Under the law, employers must now provide a 14-day written notice before taking any adverse employment action—such as termination or discipline—against a medical cannabis patient who tests positive ...

June 24th, 2025|Insights|

Legal Cannabis Shows Economic Gains and Stable Teen Use Trends

LOS ANGELES— A recent analysis from the Marijuana Policy Project (MPP) indicates that legal adult‑use cannabis sales have generated approximately $24.7 billion in state tax revenue since legalization began in 2014, with $4.4 billion collected in 2024 alone . At the same time, data from multiple sources show that teen cannabis use has declined in most states ...

June 24th, 2025|Justice|

High-Potency Cannabis Strains Impact Legal and Health Systems

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report rising visits due to high-THC cannabis use. Symptoms include acute psychosis, severe anxiety, and cannabinoid hyperemesis syndrome (CHS) a debilitating ...

June 24th, 2025|Business|

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use outside of clinical trials in the country . Associate Health Minister David Seymour announced new regulations that allow a single ...

June 23rd, 2025|World|

Psyence Group Inc. Announces C$600,000 Private Share Offering

LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news release dated June 18, 2025, provides for up to 6 million common shares at C$0.10 each, with no finder’s fees ...

June 23rd, 2025|Capital|

Texas Governor Expands Medical Cannabis Program, Vetoes THC Ban

LOS ANGELES— Texas Governor Greg Abbott has signed House Bill 46 into law, significantly expanding the state’s limited medical cannabis program, while vetoing Senate Bill 3, which aimed to ban hemp‑derived THC products—including delta‑8 gummies, vapes and edibles. Under the new legislation, known as HB 46, the Compassionate Use Program (TCUP) will broaden eligibility by adding ...

June 23rd, 2025|Justice|

Week In Review: Aurora Cannabis Denies Acquisition of MedLeaf Therapeutics; Canadian Cannabis Producers Expand Exports; Method Man and Zamnesia Partner to Launch Eight TICAL Cannabis Seeds in U.S. and Europe

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it!  Cannabis Industry Highlights 1#)Aurora Cannabis Denies Acquisition of MedLeaf Therapeutics: Aurora Cannabis Inc. publicly refuted ...

June 23rd, 2025|Business, The Week in Review|

Method Man and Zamnesia Partner to Launch Eight TICAL Cannabis Seeds in U.S. and Europe

LOS ANGELES- Zamnesia—a European online retailer specializing in cannabis seeds—has partnered with Method Man’s cannabis brand, TICAL, to launch eight exclusive premium seeds across the U.S. and Europe. The collaboration, announced in early June 2025, targets both seasoned home growers and collectors. The seed collection, personally curated and approved by the hip‑hop artist, includes strains ...

June 20th, 2025|Business|
  • Aurora Cannabis

Aurora Cannabis Denies Acquisition of MedLeaf Therapeutics

LOS ANGELES- Aurora Cannabis Inc. publicly refuted recent reports claiming it was acquiring New Zealand–based MedLeaf Therapeutics. In a statement issued on June 18, 2025, the Edmonton-headquartered company confirmed it “has not entered into any such agreement, has had no discussions with MedLeaf Therapeutics with respect to any business combination transaction, and has not made ...

June 20th, 2025|Business|

MJ and MSOS ETFs Signal High Upside on U.S. Legalization Outlook

LOS ANGELES- Investment in cannabis-focused ETFs such as Amplify’s MJ and AdvisorShares’ MSOS reflects growing investor anticipation of federal legalization-driven expansion, even amid pronounced volatility and structural headwinds. Analysts argue that rescheduling cannabis from Schedule I to Schedule III, expected following the U.S. Department of Health and Human Services recommendation, would ease tax burdens under IRS Section 280E ...

June 20th, 2025|Capital|

Legislative Wave Follows Growth of Hemp-Infused Beverage Market

LOS ANGELES- The market for hemp-derived cannabis beverages has expanded rapidly since the 2018 federal legalization of hemp, reaching an estimated value of over $1 billion today and projected to exceed $30 billion by 2035. These ready-to-drink products—including seltzers, tonics, and teas infused with cannabinoids such as delta-8 and delta-9 THC—are sold outside traditional dispensaries, ...

June 19th, 2025|Insights|

Canadian Cannabis Producers Expand Exports

LOS ANGELES- Canada’s licensed cannabis sector continues its move toward international markets, driven by strong global demand, especially for medical cannabis. During the 2023–24 fiscal year, Canada exported approximately CA$218 million of medical cannabis for commercial and scientific use, marking a significant waypoint in the industry's evolution. In the first quarter of 2025 alone, over 16 metric ...

June 19th, 2025|Capital|

Big Cannabis Companies Maintain Optimism in Florida Despite Adult‑Use Setback

LOS ANGELES- Major cannabis operators remain confident in the Florida medical market, viewing it as a strategic long‑term growth opportunity despite the failed November 2024 attempt to legalize adult‑use cannabis. In a recent analysis, Forbes notes that leading companies continue to invest in the state given its large population and substantial medical patient base Florida’s ...

June 18th, 2025|Capital|

AYR Wellness Updates Delay of Q1 2025 Interim Filings

LOS ANGELES- AYR Wellness Inc. announced that it did not complete the filing of its interim financial statements, management’s discussion and analysis, and related CEO and CFO certificates for the three-month period ended March 31, 2025, by the anticipated June 13, 2025 deadline. The delay stems from ongoing negotiations with creditors and the assessment of ...

June 18th, 2025|Capital|

NewLake Capital Partners Declares $0.43 Second Quarter 2025 Dividend

LOS ANGELES- NewLake Capital Partners, Inc. announced on June 16, 2025, that its Board of Directors has approved a cash dividend of $0.43 per share of common stock for the second quarter of 2025. The declaration underscores the internally-managed REIT’s commitment to delivering consistent returns to its shareholders. The dividend represents an annualized payout of ...

June 18th, 2025|Capital|
  • Global Cannabis Testing Market

Israel’s Health Ministry Approves Expansion of Apex Labs’ Phase 2b Psilocybin Trial for PTSD

LOS ANGELES- Apex Labs Ltd. has secured approval from Israel’s Ministry of Health (MoH) and relevant ethics boards to expand its ongoing Phase 2b SUMMIT‑90 clinical trial assessing macrodose psilocybin therapy (APEX‑90) for post-traumatic stress disorder (PTSD). The company will add two new sites: Tel Aviv University’s Institute for Psychedelic Research at the Sagol Brain Institute ...

June 18th, 2025|Business|

Ohio’s Cannabis Revenue Trends Offer Strategic Guide for Pennsylvania

LOS ANGELES- As Pennsylvania moves closer to legalizing adult-use cannabis, Ohio’s first-year revenue data and regulatory experiences offer critical insights. Since launching sales in August 2024, Ohio has generated approximately $540 million in cannabis revenue from nearly 82,000 pounds sold and over 7.5 million transactions, according to state data. These figures suggest a strong consumer ...

June 17th, 2025|Capital|

Rose Hill Apothecary Completes First Research-Grade Psilocybin Export to Brazil

LOS ANGELES- Rose Hill Apothecary, the research-grade psilocybin arm of Rose Hill Life Sciences, has executed its inaugural international export deal, shipping 18 kilograms of dried psilocybin-containing mushrooms to Biocase Brasil Importação e Comércio de Medicamentos Ltda. The export took place under Brazil’s regulatory framework to support medicinal research initiatives. The shipment marks a significant ...

June 17th, 2025|Business|

Emerging Programs Aim to Democratize Cannabis Cultivation

LOS ANGELES- Governments, industry groups, and educational institutions are launching a wave of initiatives aimed at lowering barriers to entry in cannabis cultivation and production—efforts collectively referred to as “democratizing cannabis production.” These programs focus on expanding access to resources, training, and licensing, with a particular emphasis on supporting small growers, social equity participants, and ...

June 17th, 2025|Insights|

German Court Rules Prison Cells Qualify for Cannabis Possession Rules

LOS ANGELES- A Berlin appellate court (Kammergericht) has ruled that prisoners are legally permitted to possess up to 50 grams of cannabis in their cells for personal use, classifying prison quarters as the inmates’ “habitual residence.” Under Germany’s Cannabis Act, adults may hold up to 50 grams at home, defined legally as a place of ordinary residence, ...

June 16th, 2025|World|

Planet 13 Reports Shareholder Decisions at Annual Meeting

LOS ANGELES- Planet 13 Holdings Inc. multi-state cannabis company headquartered in Las Vegas, disclosed the results of its Annual General Meeting (AGM) held on June 10, 2025. The meeting addressed key matters related to corporate governance, including the re-election of directors, amendments to the company’s equity incentive plan, and the ratification of its independent auditor. ...

June 16th, 2025|Brands|

Hawaii Governor Vetoes Medical Cannabis Expansion Bill Over Privacy Concerns

LOS ANGELES– Hawaii Governor Josh Green has vetoed House Bill 302 (HB 302), a measure aimed at expanding the state’s medical cannabis program, due to concerns over patient privacy provisions, his office confirmed on June 9, 2025. The legislation would have authorized certified medical professionals to issue cannabis certifications via telehealth and introduced several regulatory updates, ...

June 16th, 2025|Insights|

Week In Review: North Carolina Governor Proposes Cannabis Legalization to Curb Unregulated Hemp Market; ProStar SEO Identifies Key Google Ranking Factors for Cannabis Businesses

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it!  Cannabis Industry Highlights 1#) North Carolina Governor Proposes Cannabis Legalization to Curb Unregulated Hemp Market: ...

June 16th, 2025|Business, The Week in Review|

New Zealand Delegation Led by Zoë Reece Targets Multibillion‑Dollar European Medicinal Cannabis Market

LOS ANGELES- New Zealand trade delegation, including key export company Ora Pharm, is advancing into Europe’s growing medicinal cannabis market. CEO Zoë Reece is spearheading the mission, aiming to build clinical and commercial partnerships for cannabinoid-derived therapies in Europe. Reece emphasized Europe’s potential, noting that Germany alone reported a cannabis consumer market value of approximately USD 866 million in ...

June 13th, 2025|World|
Go to Top